PFG Private Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
PFG Private Wealth Management's BMY Position: Q2 2025 in Review
PFG Private Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 100 shares — an estimated $6.1K sold.
PFG Private Wealth Management first reported a position in BMY in Q3 2021 and held it in 15 quarters. The position peaked at $32K in Q3 2022. 2,297 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- PFG Private Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
- PFG Private Wealth Management sold 100 Bristol-Myers Squibb shares in Q2 2025, an estimated $6.1K.
- PFG Private Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2021 and held it in 15 quarters.
- PFG Private Wealth Management's Bristol-Myers Squibb position peaked at $32K in Q3 2022.
- 2,297 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on PFG Private Wealth Management's 13F filing for Q2 2025, filed 11 Aug 2025.